More than two-thirds of American women interviewed for a survey released by the
American Psychiatric Association (APA) say that the nation’s sagging economy has negatively affected
their lives or the lives of their loved ones. The findings also indicate women may be neglecting their own
needs while focusing on other concerns.
This two-pronged telephone survey examines the impact of the economic crisis on the mental well-being of
women both nationally Read the rest of this entry »
Archive for May 26, 2009
Results from an international, placebo-controlled trial,1 presented for the first time at the American Academy of Neurology (AAN) Annual Meeting in Seattle, U.S.A. demonstrate that Mirapexin® / Sifrol® (pramipexole) also improves depressive symptoms, a common, disabling non-motor symptom of Parkinson`s disease (PD), in addition to its established efficacy in treating the motor symptoms of PD.
The "PD-depression" Read the rest of this entry »
The US Food and Drug Administration (FDA) has approved Exforge HCT (amlodipine, valsartan, hydrochlorothiazide), the only blood pressure (BP) treatment to combine three medications in a single pill. Exforge HCT combines the number one prescribed calcium channel blocker, angiotensin receptor blocker, and diuretic in one pill, and is Read the rest of this entry »